Determinants of Infarct Core Growth During Inter-hospital Transfer for Thrombectomy.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
06 2023
Historique:
revised: 09 01 2023
received: 09 11 2022
accepted: 01 02 2023
medline: 1 6 2023
pubmed: 8 2 2023
entrez: 7 2 2023
Statut: ppublish

Résumé

Patients with acute ischemic stroke harboring a large vessel occlusion who present to primary stroke centers often require inter-hospital transfer for thrombectomy. We aimed to determine clinical and imaging factors independently associated with fast infarct growth (IG) during inter-hospital transfer. We retrospectively analyzed data from acute stroke patients with a large vessel occlusion transferred for thrombectomy from a primary stroke center to one of three French comprehensive stroke centers, with an MRI obtained at both the primary and comprehensive center before thrombectomy. Inter-hospital IG rate was defined as the difference in infarct volumes on diffusion-weighted imaging between the primary and comprehensive center, divided by the delay between the two MRI scans. The primary outcome was identification of fast progressors, defined as IG rate ≥5 mL/hour. The hypoperfusion intensity ratio (HIR), a surrogate marker of collateral blood flow, was automatically measured on perfusion imaging. A total of 233 patients were included, of whom 27% patients were fast progressors. The percentage of fast progressors was 3% among patients with HIR < 0.40 and 71% among those with HIR ≥ 0.40. In multivariable analysis, fast progression was independently associated with HIR, intracranial carotid artery occlusion, and exclusively deep infarct location at the primary center (C-statistic = 0.95; 95% confidence interval [CI], 0.93-0.98). IG rate was independently associated with good functional outcome (adjusted OR = 0.91; 95% CI, 0.83-0.99; P = 0.037). Our findings show that a HIR > 0.40 is a powerful indicator of fast inter-hospital IG. These results have implication for neuroprotection trial design, as well as informing triage decisions at primary stroke centers. ANN NEUROL 2023;93:1117-1129.

Identifiants

pubmed: 36748945
doi: 10.1002/ana.26613
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1117-1129

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS075209
Pays : United States

Informations de copyright

© 2023 American Neurological Association.

Références

Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46-e110.
Turc G, Bhogal P, Fischer U, et al. European stroke organisation (ESO)- European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke. J Neurointerv Surg 2019;11:535-538.
Gerschenfeld G, Muresan IP, Blanc R, et al. Two paradigms for endovascular thrombectomy after intravenous thrombolysis for acute ischemic stroke. JAMA Neurol 2017;74:549-556.
Weisenburger-Lile D, Blanc R, Kyheng M, et al. Direct admission versus secondary transfer for acute stroke patients treated with intravenous thrombolysis and thrombectomy: insights from the endovascular treatment in ischemic stroke registry. Cerebrovasc Dis 2019;47:112-120.
Froehler MT, Saver JL, Zaidat OO, et al. Interhospital transfer before thrombectomy is associated with delayed treatment and worse outcome in the STRATIS registry (systematic evaluation of patients treated with Neurothrombectomy devices for acute ischemic stroke). Circulation 2017;136:2311-2321.
Guenego A, Mlynash M, Christensen S, et al. Hypoperfusion ratio predicts infarct growth during transfer for thrombectomy. Ann Neurol 2018;84:616-620.
Boulouis G, Lauer A, Siddiqui AK, et al. Clinical imaging factors associated with infarct progression in patients with ischemic stroke during transfer for mechanical thrombectomy. JAMA Neurol 2017;74:1361-1367.
Mokin M, Gupta R, Guerrero WR, et al. ASPECTS decay during inter-facility transfer in patients with large vessel occlusion strokes. J Neurointerv Surg 2017;9:442-444.
Sun CH, Connelly K, Nogueira RG, et al. ASPECTS decay during inter-facility transfer predicts patient outcomes in endovascular reperfusion for ischemic stroke: a unique assessment of dynamic physiologic change over time. J Neurointerv Surg 2015;7:22-26.
Purrucker JC, Mattern N, Herweh C, et al. Electronic Alberta stroke program early CT score change and functional outcome in a drip-and-ship stroke service. J Neurointerv Surg 2020;12:252-255.
Reddy ST, Friedman E, Wu TC, et al. Rapid infarct progression in anterior circulation large vessel occlusion ischemic stroke patients during inter-facility transfer. J Stroke Cerebrovasc Dis 2020;29:105308.
Fuentes B, Alonso de Lecinana M, Ximenez-Carrillo A, et al. Futile interhospital transfer for endovascular treatment in acute ischemic stroke: the Madrid stroke network experience. Stroke 2015;46:2156-2161.
Olivot JM, Mlynash M, Inoue M, et al. Hypoperfusion intensity ratio predicts infarct progression and functional outcome in the DEFUSE 2 cohort. Stroke 2014;45:1018-1023.
Guenego A, Fahed R, Albers GW, et al. Hypoperfusion intensity ratio correlates with angiographic collaterals in acute ischaemic stroke with M1 occlusion. Eur J Neurol 2020;27:864-870.
Menon BK, Al-Ajlan FS, Najm M, et al. Association of Clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke. JAMA 2018;320:1017-1026.
Inoue M, Mlynash M, Christensen S, et al. Early diffusion-weighted imaging reversal after endovascular reperfusion is typically transient in patients imaged 3 to 6 hours after onset. Stroke 2014;45:1024-1028.
Labeyrie MA, Turc G, Hess A, et al. Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvement. Stroke 2012;43:2986-2991.
Mohammaden MH, Haussen DC, Pisani L, et al. Characterizing fast and slow Progressors in anterior circulation large vessel occlusion strokes. Interv Neuroradiol 2022;15910199221083100.
Renú Jornet A, Urra X, Laredo C, et al. Benefit from mechanical thrombectomy in acute ischemic stroke with fast and slow progression. J Neurointerv Surg 2020;12:132-135.
Ng F, Venkatraman V, Parsons M, et al. Gradient of tissue injury after stroke: rethinking the infarct versus noninfarcted dichotomy. Cerebrovasc Dis 2020;49:32-38.
Lin L, Yang J, Chen C, et al. Association of collateral status and ischemic core growth in patients with acute ischemic stroke. Neurology 2021;96:e161-e170.
Miteff F, Levi CR, Bateman GA, et al. The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain 2009;132:2231-2238.
Wheeler HM, Mlynash M, Inoue M, et al. The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion. Int J Stroke 2015;10:723-729.
Makris N, Chamard L, Mikkelsen IK, et al. Acute reperfusion without recanalization: serial assessment of collaterals within 6 h of using perfusion-weighted magnetic resonance imaging. J Cereb Blood Flow Metab 2019;39(2):251-259.
Cereda CW, Christensen S, Campbell BCV, et al. A benchmarking tool to evaluate computer tomography perfusion infarct core predictions against a DWI standard. J Cereb Blood Flow Metab 2016;36:1780-1789.
Baron JC. Protecting the ischaemic penumbra as an adjunct to thrombectomy for acute stroke. Nat Rev Neurol 2018;14:325-337.
Pruvost-Robieux E, Benzakoun J, Turc G, et al. Cathodal transcranial direct current stimulation in acute ischemic stroke: pilot randomized controlled trial. Stroke 2021;52:1951-1960.
Li W, Qi Z, Ma Q, et al. Normobaric hyperoxia combined with endovascular treatment for acute ischemic stroke patients: a randomized controlled clinical trial. Neurology 2022;99:1069.1-1069.101069.
Campbell BCV. Optimal imaging at the primary stroke center. Stroke 2020;51:1932-1940.
Hill MD, Warach S, Rostanski SK. Should primary stroke centers perform advanced imaging? Stroke 2022;53:1423-1430.
Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012;11:860-867.
Seners P, Oppenheim C, Turc G, et al. Perfusion imaging and clinical outcome in acute ischemic stroke with large core. Ann Neurol 2021;90:417-427.
Sarraj A, Hassan AE, Grotta J, et al. Optimizing patient selection for endovascular treatment in acute ischemic stroke (SELECT): a prospective, multicenter cohort study of imaging selection. Ann Neurol 2020;87:419-433.
Sarraj A, Parsons M, Bivard A, et al. Endovascular thrombectomy versus medical management in isolated M2 occlusions: pooled patient-level analysis from the EXTEND-IA trials, INSPIRE, and SELECT studies. Ann Neurol 2022;91:629-639.
Seners P, Arquizan C, Fontaine L, et al. Perfusion imaging and clinical outcome in acute minor stroke with large vessel occlusion. Stroke 2022:Stroke;53:3429-3438.
Lin L, Bivard A, Levi CR, Parsons MW. Comparison of computed tomographic and magnetic resonance perfusion measurements in acute ischemic stroke: back-to-back quantitative analysis. Stroke 2014;45:1727-1732.

Auteurs

Pierre Seners (P)

Stanford Stroke Center, Stanford University, Palo Alto, CA.
Neurology Department, A. de Rothschild Foundation Hospital, Paris, France.
Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Université de Paris, Paris, France.

Lauranne Scheldeman (L)

Stanford Stroke Center, Stanford University, Palo Alto, CA.
Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
Department of Neurosciences, Experimental Neurology KU Leuven, University of Leuven, Leuven, Belgium.
Center for Brain and Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.

Soren Christensen (S)

Stanford Stroke Center, Stanford University, Palo Alto, CA.

Michael Mlynash (M)

Stanford Stroke Center, Stanford University, Palo Alto, CA.

Adrien Ter Schiphorst (A)

Neurology Department, CHRU Gui de Chauliac, Montpellier, France.

Caroline Arquizan (C)

Neurology Department, CHRU Gui de Chauliac, Montpellier, France.

Vincent Costalat (V)

Neuroradiology Department, CHRU Gui de Chauliac, Montpellier, France.

Hilde Henon (H)

Stroke Center, University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, Lille, France.

Martin Bretzner (M)

Neuroradiology Department, CHRU Lille, Lille, France.

Jeremy J Heit (JJ)

Neuroradiology Department, Stanford University, Palo Alto, CA.

Jean-Marc Olivot (JM)

Acute Stroke Unit, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse and Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.

Maarten G Lansberg (MG)

Stanford Stroke Center, Stanford University, Palo Alto, CA.

Gregory W Albers (GW)

Stanford Stroke Center, Stanford University, Palo Alto, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH